Evaluation of hepatic iron overload in Chinese children with β-thalassemia major

Pediatric Hematology and Oncology

Volumn 28, Issue 8, 2011, Pages 702-707

  Xu, Lu Hong ^a   Fang, Jian Pei ^a   Xu, Hong Gui ^a   Weng, Wen Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Liver biopsy; Liver MRI; Serum biochemical markers; Thalassemia

Indexed keywords

COLLAGEN TYPE 4; FERRITIN; HYALURONIC ACID; LAMININ; PROCOLLAGEN;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHILDHOOD DISEASE; CHINESE; CLINICAL ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; LIVER HISTOLOGY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD; THALASSEMIA MAJOR;

ADOLESCENT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; IRON OVERLOAD; LIVER; MALE;

EID: 80055011131     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.603820     Document Type: Article

References (18)

1. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135-1146.
2. Cao A, Galanello R. Beta-thalassemia. GenetMed. 2010;12:61-76.
3. Zeng YT, Huang SZ. Disorders of haemoglobin in China. JMed Genet. 1987;24:578-583.
4. Telfer P. Update on survival in thalassemiamajor. Hemoglobin. 2009;33:S76-S80.
5. Li CG, Li CF, Li Q, et al. Thalassemia incidence and treatment in China with special reference to Shenzhen City and Guangdong province. Hemoglobin. 2009;33:296-303.
6. Fang JP, Xu LH. Hematopoietic stem cell transplantation for children with thalassemia major in China. Pediatr Blood Cancer. 2010;55:1062-1065.
7. Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemiamajor.N Engl J Med. 2000;343:327-331. (Pubitemid 30616698)
8. Jensen PD. Evaluation of iron overload. Br J Haematol. 2004;124:697-711.
9. Angelucci E, Baronciani D, Lucarelli G, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol. 1995;89:757-761.
10. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology. 1997;113:1609-1616. (Pubitemid 27461247)
11. Gandon Y,OlivíeD,Guyader D, et al.Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004;363:357-362. (Pubitemid 38169542)
12. Shen J, Griffith JF, Cheng LN, et al. Bonemarrow MR imaging as predictors of outcome in hemopoietic stem cell transplantation. Eur Radiol. 2008;18:1884-1891.
13. Porter JB. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemiamajor and sickle cell disease. Hemoglobin. 2009;33:S37-S45.
14. Li CK, Chik KW, Lam CW, et al. Liver disease in transfusion dependent thalassaemiamajor. Arch Dis Child. 2002;86:344-347. (Pubitemid 34478230)
15. Papastamataki M, Delaporta P, Premetis E, et al. Evaluation of liver fibrosis in patients with thalassemia: the important role of hyaluronic acid. Blood Cells Mol Dis. 2010;45:215-218.
16. Sheth S. SQUID biosusceptometry in the measurement of hepatic iron. Pediatr Radiol. 2003;33:373-377. (Pubitemid 36748389)
17. Chan YL, Li CK, Lam CW, et al. Liver iron estimation in beta-thalassaemia: comparison ofMRI biochemical assay and histological grading. Clin Radiol. 2001;56:911-916. (Pubitemid 35023830)
18. Levin TL, Sheth SS, Ruzal-Shapiro C, et al. MRI marrow observations in thalassemia: the effects of the primary disease, transfusional therapy, and chelation. Pediatr Radiol. 1995;25:607-613.